The Japanese drug maker Eisai said it would withdraw the weightloss drug Belviq from the U.S. market after the FDA expressed concerns about an increased occurrence of cancer reported in people who used the product. httpsbuff.ly322Cl7KÂ

The Japanese drug maker Eisai said it would withdraw the weight-loss drug Belviq from the U.S. market after the FDA expressed concerns about an increased occurrence of cancer reported in people who used the product. https://buff.ly/322Cl7K 

The Japanese drug maker Eisai said it would withdraw the weight-loss drug Belviq from the U.S. market after the FDA expressed concerns about an increased occurrence of cancer reported in people who used the product. https://buff.ly/322Cl7K 

More From BioPortfolio on "The Japanese drug maker Eisai said it would withdraw the weight-loss drug Belviq from the U.S. market after the FDA expressed concerns about an increased occurrence of cancer reported in people who used the product. https://buff.ly/322Cl7K "